We appreciate the opportunity to respond to the issue raised by Ramachandran regarding our article1on perioperative outcomes in patients with modified metabolic syndrome (mMetS) who undergo noncardiac surgery. We thank the author for his comment that “[our] findings may indeed change the way physicians ... look at obese patients in the future.” In his letter, the author raises the issue about whether the current study proves the increased risk of mMetS or simply proves “that the preoperative presence of two independent risk factors (and one protective factor) is more significant than having one protective factor?”

Our study was designed to better understand the obesity paradox, the apparent protective effect of obesity on surgical mortality,2by distinguishing patients who were obese but “metabolically healthy” from patients with MetS.3The major new findings of our study were that patients with mMetS undergoing noncardiac surgery were at higher risk for cardiac, pulmonary, renal, and central nervous system complications.1Unlike the obesity paradox observed for mortality,4our study did not detect any evidence of a “protective effect” of obesity for these complications. Our analysis does not indicate whether the increased risk associated with the mMetS is due simply to the additive effects of diabetes, hypertension, and obesity, which together make up the modified metabolic syndrome (mMetS). In other words, we have not answered the question of whether the whole is greater than the sum of the parts. However, whether our findings represent, in a statistical sense, an additive effect or an interaction effect is less important than the simple recognition that mMetS is associated with a significantly higher risk of major postoperative complications. In particular, patients with mMetS have a 2- to 3-fold increased risk of cardiac complications and a 3- to 7-fold increased risk of renal complications. These findings are especially striking in light of the previous literature demonstrating an apparently protective effect of obesity on mortality during the perioperative period. From the standpoint of regression modeling, the increased risk associated with mMetS may boil down to the question of “simple math or aberrant physiology.” However, in clinical practice, the recognition that patients with mMetS are at a much higher risk of cardiac, pulmonary, and renal complications has both biologic plausibility and important implications for the management of these patients.

*University of Rochester School of Medicine, Rochester, New York. laurent_glance@urmc.rochester.edu

Glance LG, Wissler R, Mukamel DB, Li Y, Diachun CA, Salloum R, Fleming FJ, Dick AW: Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology 2010; 113:859–72
Dindo D, Muller MK, Weber M, Clavien PA: Obesity in general elective surgery. Lancet 2003; 361:2032–5
Neligan PJ, Fleisher LA: Obesity and diabetes: Evidence of increased perioperative risk? Anesthesiology 2006; 104:398–400
Mullen JT, Moorman DW, Davenport DL: The obesity paradox: Body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009; 250:166–72